The criticality of the COVID-19 pandemic saw the emergence of fast-paced study start-ups, with the goal to get treatments approved as quickly as possible.

Learn how Calyx’s IRT teams rose to the emergency and built multiple IRT systems in less than two weeks to support a trial for a novel, potential COVID-19 treatment.

Stay Updated

Never miss a beat. Sign up to receive emails covering industry news and useful content to help you advance clinical development.

  • This field is for validation purposes and should be left unchanged.